Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
McKinsey
Boehringer Ingelheim
Julphar
Chinese Patent Office
Dow
Harvard Business School
Express Scripts
AstraZeneca
Moodys

Generated: August 23, 2017

DrugPatentWatch Database Preview

Doxylamine succinate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for doxylamine succinate and what is the scope of doxylamine succinate freedom to operate?

Doxylamine succinate
is the generic ingredient in eight branded drugs marketed by Copley Pharm, Quantum Pharmics, Sanofi Aventis Us, Pfizer, Par Pharm, LNK, Chattem, Perrigo, Actavis Labs Fl Inc, and Duchesnay, and is included in twelve NDAs. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for doxylamine succinate. Thirty-one suppliers are listed for this compound.

Summary for Generic Name: doxylamine succinate

Tradenames:8
Patents:5
Applicants:10
NDAs:12
Drug Master File Entries: see list14
Suppliers / Packagers: see list31
Bulk Api Vendors: see list47
Clinical Trials: see list179
Patent Applications: see list1,060
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:doxylamine succinate at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Perrigo
DOXYLAMINE SUCCINATE
doxylamine succinate
TABLET;ORAL040167-001Sep 18, 1996OTCNoNo► Subscribe► Subscribe► Subscribe
Quantum Pharmics
DOXYLAMINE SUCCINATE
doxylamine succinate
TABLET;ORAL088603-001Aug 7, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Sanofi Aventis Us
BENDECTIN
doxylamine succinate; pyridoxine hydrochloride
TABLET, EXTENDED RELEASE;ORAL010598-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Sanofi Aventis Us
DECAPRYN
doxylamine succinate
TABLET;ORAL006412-015Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Duchesnay
DICLEGIS
doxylamine succinate; pyridoxine hydrochloride
TABLET, DELAYED RELEASE;ORAL021876-001Apr 8, 2013ABRXYesYes► Subscribe► SubscribeY ► Subscribe
Duchesnay
BONJESTA
doxylamine succinate; pyridoxine hydrochloride
TABLET, EXTENDED RELEASE;ORAL209661-001Nov 7, 2016RXYesYes► Subscribe► SubscribeY ► Subscribe
Chattem
UNISOM
doxylamine succinate
TABLET;ORAL018066-001Approved Prior to Jan 1, 1982OTCYesYes► Subscribe► Subscribe► Subscribe
Par Pharm
DOXY-SLEEP-AID
doxylamine succinate
TABLET;ORAL070156-001Jul 2, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE
doxylamine succinate; pyridoxine hydrochloride
TABLET, DELAYED RELEASE;ORAL205811-001Aug 19, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Duchesnay
BONJESTA
doxylamine succinate; pyridoxine hydrochloride
TABLET, EXTENDED RELEASE;ORAL209661-001Nov 7, 2016RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Medtronic
Boehringer Ingelheim
Merck
Moodys
Cipla
Farmers Insurance
Baxter
Federal Trade Commission
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot